Antigen-based immune therapeutics for type 1 diabetes: Magic bullets or ordinary blanks?

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Mallone, Roberto ^a,b,c   Culina, Slobodan ^a,b   Boitard, Christian ^a,b,c  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; B25ASP INSULIN; BHT 3021; CYCLOSPORIN A; DENDRITIC CELL VACCINE; DIAMYD; FREUND ADJUVANT; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEAT SHOCK PROTEIN 60; INSULIN; INSULIN BETA CHAIN; INSULIN BETA CHAIN 9 23; INSULIN GLARGINE; INSULIN ZINC SUSPENSION; ISLET GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNIT RELATED PROTEIN; METFORMIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NBI 6024; PIG INSULIN; PLASMID DNA; PLASMID DNA PROINSULIN; PREPROINSULIN; PROINSULIN; PROINSULIN PEPTIDE C19 A3; RECOMBINANT GLUTAMATE DECARBOXYLASE VACCINE; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ANTIGEN; BIOLOGICAL MARKER;

APOPTOSIS; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; DENDRITIC CELL; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; GENETIC SUSCEPTIBILITY; HUMAN; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; META ANALYSIS (TOPIC); MULTIPLE SCLEROSIS; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; ANIMAL; ARTICLE; CYTOLOGY; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; MOUSE; T LYMPHOCYTE;

ANIMALS; ANTIGENS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOTHERAPY; MICE; MICE, INBRED NOD; T-LYMPHOCYTES;

EID: 79959207833     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/286248     Document Type: Review

References (123)

1. Mestas J., Hughes C. C. W., Of mice and not men: differences between mouse and human immunology Journal of Immunology 2004 172 5 2731 2738 (Pubitemid 38263654)
2. Sreenan S., Pick A. J., Levisetti M., Baldwin A. C., Pugh W., Polonsky K. S., Increased -cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse Diabetes 1999 48 5 989 996 (Pubitemid 29226344)
3. Gepts W., Pathologic anatomy of the pancreas in juvenile diabetes mellitus Diabetes 1965 14 10 619 633
4. Foulis A. K., Farquharson M. A., Hardman R., Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus Diabetologia 1987 30 5 333 343 (Pubitemid 17083703)
5. Foulis A. K., Liddle C. N., Farquharson M. A., The histopathology of the pancreas in Type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom Diabetologia 1986 29 5 267 274 (Pubitemid 16080921)
6. Klinke D. J., Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus PLoS ONE 2008 3 1
7. Sherry N. A., Tsai E. B., Herold K. C., Natural history of -cell function in type 1 diabetes Diabetes 2005 54 supplement 2 S32 S39
8. Akirav E., Kushner J. A., Herold K. C., cell mass and type 1 diabetes: going, going, gone? Diabetes 2008 57 11 2883 2888
9. Wen L. I., Ley R. E., Volchkov P. Y. U., Stranges P. B., Avanesyan L., Stonebraker A. C., Hu C., Wong F. S., Szot G. L., Bluestone J. A., Gordon J. I., Chervonsky A. V., Innate immunity and intestinal microbiota in the development of Type 1 diabetes Nature 2008 455 7216 1109 1113
10. Fourlanos S., Narendran P., Byrnes G. B., Colman P. G., Harrison L. C., Insulin resistance is a risk factor for progression to Type 1 diabetes Diabetologia 2004 47 10 1661 1667 (Pubitemid 40022398)
11. Pagano G., Tagliaferro V., Carta Q., Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes Diabetologia 1983 24 5 351 354 (Pubitemid 13092221)
12. Hamilton J., Cummings E., Zdravkovic V., Finegood D., Daneman D., Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial Diabetes Care 2003 26 1 138 143 (Pubitemid 36929006)
13. Lund S. S., Tarnow L., Astrup A. S., Hovind P., Jacobsen P. K., Alibegovic A. C., Parving I., Pietraszek L., Frandsen M., Rossing P., Parving H. H., Vaag A. A., Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study PLoS ONE 2008 3 10
14. Stiller C. R., Dupre J., Gent M., Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset Science 1984 223 4643 1362 1367 (Pubitemid 14161003)
15. Gottlieb P. A., Quinlan S., Krause-Steinrauf H., Greenbaum C. J., Wilson D. M., Rodriguez H., Schatz D. A., Moran A. M., Lachin J. M., Skyler J. S., Failure to preserve -cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new-onset type 1 diabetes Diabetes Care 2010 33 4 826 832
16. Bluestone J. A., Herold K., Eisenbarth G., Genetics, pathogenesis and clinical interventions in type 1 diabetes Nature 2010 464 7293 1293 1300
17. Lieberman S. M., DiLorenzo T. P., A comprehensive guide to antibody and T-cell responses in type 1 diabetes Tissue Antigens 2003 62 5 359 377 (Pubitemid 37338877)
18. Lieberman S. M., Evans A. M., Han B., Takaki T., Vinnitskaya Y., Caldwell J. A., Serreze D. V., Shabanowitz J., Hunt D. F., Nathenson S. G., Santamaria P., DiLorenzo T. P., Identification of the cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8384 8388 (Pubitemid 36842554)
19. Mallone R., Martinuzzi E., Blancou P., Novelli G., Afonso G., Dolz M., Bruno G., Chaillous L., Chatenoud L., Bach J. M., Van Endert P., CD8+ T-cell responses identify -cell autoimmunity in human type 1 diabetes Diabetes 2007 56 3 613 621 (Pubitemid 46348452)
20. Thbault-Baumont K., Dubois-Laforgue D., Krief P., Briand J. P., Halbout P., Vallon-Geoffroy K., Morin J., Laloux V., Lehuen A., Carel J. C., Jami J., Muller S., Boitard C., Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice Journal of Clinical Investigation 2003 111 6 851 857 (Pubitemid 37074960)
21. Faideau B., Lotton C., Lucas B., Tardivel I., Elliott J. F., Boitard C., Carel J. C., Tolerance to proinsulin-2 is due to radioresistant thymic cells Journal of Immunology 2006 177 1 53 60 (Pubitemid 43939115)
22. Moriyama H., Abiru N., Paronen J., Sikora K., Liu E., Miao D., Devendra D., Beilke J., Gianani R., Gill R. G., Elsenbarth G. S., Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse Proceedings of the National Academy of Sciences of the United States of America 2003 100 18 10376 10381 (Pubitemid 37071886)
23. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., Yu L., Wegmann D. R., Hutton J. C., Elliott J. F., Eisenbarth G. S., Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice Nature 2005 435 7039 220 223 (Pubitemid 40685949)
24. Daniel D., Gill R. G., Schloot N., Wegmann D., Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice European Journal of Immunology 1995 25 4 1056 1062
25. Wong F. S., Karttunen J., Dumont C., Wen LI., Visintin I., Pilip I. M., Shastri N., Pamer E. G., Janeway C. A., Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library Nature Medicine 1999 5 9 1026 1031 (Pubitemid 29439573)
26. Krishnamurthy B., Dudek N. L., McKenzie M. D., Purcell A. W., Brooks A. G., Gellert S., Colman P. G., Harrison L. C., Lew A. M., Thomas H. E., Kay T. W. H., Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP Journal of Clinical Investigation 2006 116 12 3258 3265 (Pubitemid 44878640)
27. Krishnamurthy B., Mariana L., Gellert S. A., Colman P. G., Harrison L. C., Lew A. M., Santamaria P., Thomas H. E., Kay T. W. H., Autoimmunity to both proinsulin and IGRP is required for diabetes in nonobese diabetic 8.3 TCR transgenic mice Journal of Immunology 2008 180 7 4458 4464
28. Amranl A., Verdaguer J., Serra P., Tafuro S., Tan R., Santamaria P., Progression of autoimmune diabetes driven by avidity maturation of a T- cell population Nature 2000 406 6797 739 742
29. Lieberman S. M., Takaki T., Han B., Santamaria P., Serreze D. V., DiLorenzo T. P., Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase Journal of Immunology 2004 173 11 6727 6734 (Pubitemid 39541058)
30. Kubosaki A., Gross S., Miura J., Saeki K., Zhu M., Nakamura S., Hendriks W., Notkins A. L., Targeted disruption of the IA-2 gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice Diabetes 2004 53 7 1684 1691 (Pubitemid 38857025)
31. Jaeckel E., Klein L., Martin-Orozco N., Von Boehmer H., Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase Journal of Experimental Medicine 2003 197 12 1635 1644 (Pubitemid 36745339)
32. Ludvigsson J., Faresj M., Hjorth M., Axelsson S., Chramy M., Pihl M., Vaarala O., Forsander G., Ivarsson S., Johansson C., Lindh A., Nilsson N.., man J., rtqvist E., Zerhouni P., Casas R., GAD treatment and insulin secretion in recent-onset type 1 diabetes The New England Journal of Medicine 2008 359 18 1909 1920
33. Chandra J., Zhivotovsky B., Zaitsev S., Juntti-Berggren L., Berggren P. O., Orrenius S., Role of apoptosis in pancreatic -cell death in diabetes Diabetes 2001 50 supplement 1 S44 S47
34. Skowera A., Ellis R. J., Varela-Calvio R., Arif S., Huang G. C., Van-Krinks C., Zaremba A., Rackham C., Allen J. S., Tree T. I. M., Zhao M., Dayan C. M., Sewell A. K., Unger W., Drijfhout J. W., Ossendorp F., Roep B. O., Peakman M., CTLs are targeted to kill cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope Journal of Clinical Investigation 2008 118 10 3390 3402
35. Atkinson M. A., Maclaren N. K., Luchetta R., Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy Diabetes 1990 39 8 933 937
36. Gladstone P., Nepom G. T., The prevention of IDDM: injecting insulin into the cytokine network Diabetes 1995 44 7 859 862
37. Schloot N., Eisenbarth G. S., Isohormonal therapy of endocrine autoimmunity Immunology Today 1995 16 6 289 294
38. Shah S. C., Malone J. I., Simpson N. E., A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus The New England Journal of Medicine 1989 320 9 550 554 (Pubitemid 19070538)
39. Keller R. J., Eisenbarth G. S., Jackson R. A., Insulin prophylaxis in individuals at high risk of type I diabetes The Lancet 1993 341 8850 927 928 (Pubitemid 23109113)
40. Fchtenbusch M., Rabl W., Grassl B., Bachmann W., Standl E., Ziegler A. G., Delay of Type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing insulin Prophylaxis Pilot Trial Diabetologia 1998 41 5 536 541 (Pubitemid 28206823)
41. Diabetes Prevention Trial-Type 1 Diabetes Study G, Effects of insulin in relatives of patients with type 1 diabetes mellitus The New England Journal of Medicine 2002 346 1685 1691
42. Carel J. C., Landais P., Bougnres P., Rodriguez-Villar C., Casamitjana R., Conget I., Therapy to prevent type 1 diabetes mellitus The New England Journal of Medicine 2002 347 14 1115 1116
43. Gury J. C., Galbiati F., Smiroldo S., Adorini L., Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and 2-microglobulin-deficient BALB/c mice Journal of Experimental Medicine 1996 183 2 485 497
44. Volund A., Brange J., Drejer K., Jensen I., Markussen J., Ribel U., Sorensen A. R., Schlichtkrull J., In vitro and in vivo potency of insulin analogues designed for clinical use Diabetic Medicine 1991 8 9 839 847
45. Karounos D. G., Bryson J. S., Cohen D. A., Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice Journal of Clinical Investigation 1997 100 6 1344 1348 (Pubitemid 27425758)
46. Chaillous L., Lefevre H., Thivolet C., Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabete Insuline Orale group The Lancet 2000 356 545 549 (Pubitemid 30611859)
47. Pozzilli P., Pitocco D., Visalli N., Cavallo M. G., Buzzetti R., Crin A., Spera S., Suraci C., Multari G., Cervoni M., Manca Bitti M. L., Matteoli M. C., Marietti G., Ferrazzoli F., Cassone Faldetta M. R., Giordano C., Sbriglia M., Sarugeri E., Ghirlanda G., No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII) Diabetologia 2000 43 8 1000 1004 (Pubitemid 30655719)
48. Ergun-Longmire B., Marker J., Zeidler A., Rapaport R., Raskin P., Bode B., Schatz D., Vargas A., Rogers D., Schwartz S., Malone J., Krischer J., Maclaren N. K., Oral insulin therapy to prevent progression of immune-mediated (Type 1) diabetes Annals of the New York Academy of Sciences 2004 1029 260 277 (Pubitemid 40298536)
49. Skyler J. S., Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial-type 1 Diabetes Care 2005 28 5 1068 1076 (Pubitemid 40616615)
50. Harrison L. C., Honeyman M. C., Steele C. E., Stone N. L., Sarugeri E., Bonifacio E., Couper J. J., Colman P. G., Pancreatic -cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes Diabetes Care 2004 27 10 2348 2355 (Pubitemid 39281384)
51. Nnt-Salonen K., Kupila A., Simell S., Siljander H., Salonsaari T., Hekkala A., Korhonen S., Erkkola R., Sipil J. I., Haavisto L., Siltala M., Tuominen J., Hakalax J., Hyty H., Ilonen J., Veijola R., Simell T., Knip M., Simell O., Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial The Lancet 2008 372 9651 1746 1755
52. Fourlanos S., Perry C., Gellert S. A., Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes Diabetes 2011 60 4 1237 1245
53. Toma A., Haddouk S., Briand J. P., Camoin L., Gahery H., Connan F., Dubois-Laforgue D., Caillat-Zucman S., Guillet J. G., Carel J. C., Muller S., Choppin J., Boitard C., Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients Proceedings of the National Academy of Sciences of the United States of America 2005 102 30 10581 10586 (Pubitemid 41061597)
54. Toma A., Laka T., Haddouk S., Luce S., Briand J. P., Camoin L., Connan F., Lambert M., Caillat-Zucman S., Carel J. C., Muller S., Choppin J., Lemonnier F., Boitard C., Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A0201 transgenic mice and in human type 1 diabetes Diabetes 2009 58 2 394 402
55. Keymeulen B., Vandemeulebroucke E., Ziegler A. G., Mathieu C., Kaufman L., Hale G., Gorus F., Goldman M., Walter M., Candon S., Schandene L., Crenier L., De Block C., Seigneurin J. M., De Pauw P., Pierard D., Weets I., Rebello P., Bird P., Berrie E., Frewin M., Waldmann H., Bach J. F., Pipeleers D., Chatenoud L., Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes The New England Journal of Medicine 2005 352 25 2598 2608 (Pubitemid 41007846)
56. Chramy M., Skoglund C., Johansson I., Ludvigsson J., Hampe C. S., Casas R., GAD-alum treatment in patients with type 1 diabetes and the subsequent effect on GADA IgG subclass distribution, GAD enzyme activity and humoral response Clinical Immunology 2010 137 31 40
57. Koczwara K., Bonifacio E., Ziegler A. G., Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes Diabetes 2004 53 1 1 4 (Pubitemid 38044690)
58. Casares S., Bona C. A., Brumeanu T. D., Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras Protein Engineering 2001 14 3 195 200 (Pubitemid 32487974)
59. Martinez N. R., Augstein P., Moustakas A. K., Papadopoulos G. K., Gregori S., Adorini L., Jackson D. C., Harrison L. C., Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide Journal of Clinical Investigation 2003 111 9 1365 1371 (Pubitemid 36554707)
60. Pugliese A., Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword Journal of Clinical Investigation 2003 111 9 1280 1282 (Pubitemid 36554697)
61. Mallone R., Kochik S. A., Laughlin E. M., Gersuk V. H., Reijonen H., Kwok W. W., Nepom G. T., Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells Diabetes 2004 53 4 971 977 (Pubitemid 38436609)
62. Mallone R., Kochik S. A., Reijonen H., Carson B., Ziegler S. F., Kwok W. W., Nepom G. T., Functional avidity directs T-cell fate in autoreactive CD4+ T cells Blood 2005 106 8 2798 2805 (Pubitemid 41510756)
63. Bielekova B., Goodwin B., Richert N., Cortese I., Kondo T., Afshar G., Gran B., Eaton J., Antel J., Frank J. A., McFarland H. F., Martin R., Encephalitogenic potential of the myelin basic protein peptide (amino acids 8399) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand Nature Medicine 2000 6 10 1167 1175
64. Kappos L., Comi G., Panitch H., Oger J., Antel J., Conlon P., Steinman L., Comi G., Kappos L., Oger J., Panitch H., Rae-Grant A., Castaldo J., Eckert N., Guarnaccia J. B., Mills P., Johnson G., Calabresi P. A., Pozzilli C., Bastianello S., Giugni E., Witjas T., Cozzone P., Pelletier J., Phlau D., Przuntek H., Hoffmann V., Bever Jr. C., Katz E., Clanet M., Berry I., Brassat D., Brunet I., Edan G., Duquette P., Radue E.-W., Schtt D., Lienert C., Taksaoui A., Rodegher M., Filippi M., Evans A., Bourgouin P., Zijdenbos A., Salem S., Ling N., Alleva D., Johnson E., Gaur A., Crowe P., Liu X.-J., Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial Nature Medicine 2000 6 10 1176 1182
65. Genain C. P., Zamvil S. S., Specific immunotherapy: one size does not fit all Nature Medicine 2000 6 10 1098 1100
66. Orban T., Farkas K., Jalahej H., Kis J., Treszl A., Falk B., Reijonen H., Wolfsdorf J., Ricker A., Matthews J. B., Tchao N., Sayre P., Bianchine P., Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy Journal of Autoimmunity 2010 34 4 408 415
67. Thrower S. L., James L., Hall W., Green K. M., Arif S., Allen J. S., Van-Krinks C., Lozanoska-Ochser B., Marquesini L., Brown S., Wong F. S., Dayan C. M., Peakman M., Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study Clinical and Experimental Immunology 2009 155 2 156 165
68. Arif S., Tree T. I., Astill T. P., Tremble J. M., Bishop A. J., Dayan C. M., Roep B. O., Peakman M., Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health Journal of Clinical Investigation 2004 113 3 451 463 (Pubitemid 38544189)
69. Raz I., Elias D., Avron A., Tamir M., Metzger M., Cohen I. R., -cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial The Lancet 2001 358 9295 1749 1753 (Pubitemid 33152998)
70. Raz I., Avron A., Tamir M., Metzger M., Symer L., Eldor R., Cohen I. R., Elias D., Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial Diabetes/Metabolism Research and Reviews 2007 23 4 292 298 (Pubitemid 46851470)
71. Zanin-Zhorov A., Nussbaum G., Franitza S., Cohen I. R., Lider O., T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors The FASEB Journal 2003 17 11 1567 1569
72. Sloan-Lancaster J., Allen P. M., Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology Annual Review of Immunology 1996 14 1 27 (Pubitemid 26130175)
73. Daniel D., Wegmann D. R., Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23) Proceedings of the National Academy of Sciences of the United States of America 1996 93 2 956 960 (Pubitemid 26041202)
74. Alleva D. G., Crowe P. D., Jin L., Kwok W. W., Ling N., Gottschalk M., Conlon P. J., Gottlieb P. A., Putnam A. L., Gaur A., A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin Journal of Clinical Investigation 2001 107 2 173 180 (Pubitemid 32096833)
75. Alleva D. G., Gaur A., Jin L., Wegmann D., Gottlieb P. A., Pahuja A., Johnson E. B., Motheral T., Putnam A., Crowe P. D., Ling N., Boehme S. A., Conlon P. J., Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide Diabetes 2002 51 7 2126 2134 (Pubitemid 34729017)
76. Alleva D. G., Maki R. A., Putnam A. L., Robinson J. M., Kipnes M. S., Dandona P., Marks J. B., Simmons D. L., Greenbaum C. J., Jimenez R. G., Conlon P. J., Gottlieb P. A., Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope Scandinavian Journal of Immunology 2006 63 1 59 69
77. Walter M., Philotheou A., Bonnici F., Ziegler A. G., Jimenez R., No effect of the altered peptide ligand NBI-6024 on -cell residual function and insulin needs in new-onset type 1 diabetes Diabetes Care 2009 32 11 2036 2040
78. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J. V., Steinman R. M., Nussenzweig M. C., Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo Journal of Experimental Medicine 2001 194 6 769 779 (Pubitemid 32983013)
79. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M. C., Steinman R. M., Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance Journal of Experimental Medicine 2002 196 12 1627 1638 (Pubitemid 36026474)
80. Bonifaz L. C., Bonnyay D. P., Charalambous A., Darguste D. I., Fujii S. I., Soares H., Brimnes M. K., Moltedo B., Moran T. M., Steinman R. M., In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination Journal of Experimental Medicine 2004 199 6 815 824 (Pubitemid 38375201)
81. Dudziak D., Kamphorst A. O., Heidkamp G. F., Buchholz V. R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H. W., Chae G. P., Steinman R. M., Nussenzweig M. C., Differential antigen processing by dendritic cell subsets in vivo Science 2007 315 5808 107 111 (Pubitemid 46196991)
82. Mukhopadhaya A., Hanafusa T., Jarchum I., Chen YI. G., Iwai Y., Serreze D. V., Steinman R. M., Tarbell K. V., DiLorenzo T. P., Selective delivery of cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice Proceedings of the National Academy of Sciences of the United States of America 2008 105 17 6374 6379 (Pubitemid 351758353)
83. Mukherjee G., Dilorenzo T. P., The immunotherapeutic potential of dendritic cells in type 1 diabetes Clinical and Experimental Immunology 2010 161 2 197 207
84. Miller S. D., Wetzig R. P., Claman H. N., The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells Journal of Experimental Medicine 1979 149 3 758 773 (Pubitemid 9137687)
85. Miller S. D., Turley D. M., Podojil J. R., Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease Nature Reviews Immunology 2007 7 9 665 677 (Pubitemid 47327394)
86. Luo X., Herold K. C., Miller S. D., Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity 2010 32 4 488 499
87. Kennedy M. K., Tan L. J., Dal Canto M. C., Tuohy V. K., Lu Z., Trotter J. L., Miller S. D., Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides Journal of Immunology 1990 144 3 909 915 (Pubitemid 20065030)
88. Fife B. T., Guleria I., Bupp M. G., Eagar T. N., Tang Q., Bour-Jordan H., Yagita H., Azuma M., Sayegh M. H., Bluestone J. A., Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway Journal of Experimental Medicine 2006 203 12 2737 2747 (Pubitemid 44833349)
89. Inaba K., Turley S., Yamaide F., Iyoda T., Mahnke K., Inaba M., Pack M., Subklewe M., Sauter B., Sheff D., Albert M., Bhardwaj N., Mellman I., Steinman R. M., Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells Journal of Experimental Medicine 1998 188 11 2163 2173 (Pubitemid 28562532)
90. Donnelly J. J., Wahren B., Liu M. A., DNA vaccines: progress and challenges Journal of Immunology 2005 175 2 633 639 (Pubitemid 41094942)
91. Blancou P., Mallone R., Martinuzzi E., Svre S., Pogu S., Novelli G., Bruno G., Charbonnel B., Dolz M., Chaillous L., Van Endert P., Bach J. M., Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients Journal of Immunology 2007 178 11 7458 7466 (Pubitemid 46847474)
92. Martinuzzi E., Lemonnier F. A., Boitard C., Mallone R., Measurement of CD8+ T cell responses in human type 1 diabetes Annals of the New York Academy of Sciences 2008 1150 61 67
93. Bluestone J. A., Thomson A. W., Shevach E. M., Weiner H. L., What does the future hold for cell-based tolerogenic therapy? Nature Reviews Immunology 2007 7 8 650 654 (Pubitemid 47123553)
94. Tang Q., Henriksen K. J., Bi M., Finger E. B., Szot G., Ye J., Masteller E. L., McDevitt H., Bonyhadi M., Bluestone J. A., In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes Journal of Experimental Medicine 2004 199 11 1455 1465 (Pubitemid 38780401)
95. Tarbell K. V., Yamazaki S., Olson K., Toy P., Steinman R. M., CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes Journal of Experimental Medicine 2004 199 11 1467 1477 (Pubitemid 38780402)
96. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., Roncarolo M. G., Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients Journal of Immunology 2006 177 12 8338 8347 (Pubitemid 44893795)
97. Putnam A. L., Brusko T. M., Lee M. R., Liu W., Szot G. L., Ghosh T., Atkinson M. A., Bluestone J. A., Expansion of human regulatory T-cells from patients with type 1 diabetes Diabetes 2009 58 3 652 662
98. Long S. A., Walker M. R., Rieck M., James E., Kwok W. W., Sanda S., Pihoker C., Greenbaum C., Nepom G. T., Buckner J. H., Functional islet-specific Treg can be generated from CD4+CD25 T cells of healthy and type 1 diabetic subjects European Journal of Immunology 2009 39 2 612 620
99. Dromey J. A., Lee B. H., Yu H., Generation and expansion of regulatory human CD4(+) T-cell clones specific for pancreatic islet autoantigens Journal of Autoimmunity 2010 36 47 55
100. Zhou X., Bailey-Bucktrout S. L., Jeker L. T., Penaranda C., Martnez-Llordella M., Ashby M., Nakayama M., Rosenthal W., Bluestone J. A., Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo Nature Immunology 2009 10 9 1000 1007
101. Dhodapkar M. V., Steinman R. M., Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans Blood 2002 100 1 174 177 (Pubitemid 35177444)
102. Hackstein H., Morelli A. E., Thomson A. W., Designer dendritic cells for tolerance induction: guided not misguided missiles Trends in Immunology 2001 22 8 437 442 (Pubitemid 32709978)
103. Machen J., Harnaha JO., Lakomy R., Styche A., Trucco M., Giannoukakis N., Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells Journal of Immunology 2004 173 7 4331 4341 (Pubitemid 39280661)
104. Creusot R. J., Yaghoubi S. S., Chang P., Chia J., Contag C. H., Gambhir S. S., Fathman C. G., Lymphoid tissue-specific homing of bone marrow-derived dendritic cells Blood 2009 113 26 6638 6647
105. Kusmartsev S., Nefedova Y., Yoder D., Gabrilovich D. I., Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species Journal of Immunology 2004 172 2 989 999 (Pubitemid 38113758)
106. Zea A. H., Rodriguez P. C., Atkins M. B., Hernandez C., Signoretti S., Zabaleta J., McDermott D., Quiceno D., Youmans A., O'Neill A., Mier J., Ochoa A. C., Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion Cancer Research 2005 65 8 3044 3048 (Pubitemid 40524582)
107. Huang BO., Pan P. Y., Li Q., Sato A. I., Levy D. E., Bromberg J., Divino C. M., Chen S. H., Gr-1CD115 immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host Cancer Research 2006 66 2 1123 1131 (Pubitemid 43165981)
108. Garcia M. R., Ledgerwood L., Yang Y., Xu J., Lal G., Burrell B., Ma G., Hashimoto D., Li Y., Boros P., Grisotto M., Van Rooijen N., Matesanz R., Tacke F., Ginhoux F., Ding Y., Chen S.-H., Randolph G., Merad M., Bromberg J. S., Ochando J. C., Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice Journal of Clinical Investigation 2010 120 7 2486 2496
109. Yin B., Ma G., Yen C.-Y., Zhou Z., Wang G. X., Divino C. M., Casares S., Chen S.-H., Yang W.-C., Pan P.-Y., Myeloid-derived suppressor cells prevent type 1 diabetes in murine models Journal of Immunology 2010 185 10 5828 5834
110. Herold K. C., Brooks-Worrell B., Palmer J., Dosch H. M., Peakman M., Gottlieb P., Reijonen H., Arif S., Spain L. M., Thompson C., Lachin J. M., Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes Diabetes 2009 58 11 2588 2595
111. Mannering S. I., Wong F. S., Durinovic-Bell I., Brooks-Worrell B., Tree T. I., Cilio C. M., Schloot N. C., Mallone R., Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes Clinical and Experimental Immunology 2010 162 2 197 209
112. Mallone R., Mannering S. I., Brooks-Worrell B. M., Durinovic-Bell I., Cilio C. M., Wong F. S., Schloot N. C., Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society Clinical and Experimental Immunology 2011 163 1 33 49
113. Gaglia J. L., Guimaraes A. R., Harisinghani M., Turvey S. E., Jackson R., Benoist C., Mathis D., Weissleder R., Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients Journal of Clinical Investigation 2011 121 1 442 445
114. Pescovitz M. D., Greenbaum C. J., Krause-Steinrauf H., Becker D. J., Gitelman S. E., Goland R., Gottlieb P. A., Marks J. B., McGee P. F., Moran A. M., Raskin P., Rodriguez H., Schatz D. A., Wherrett D., Wilson D. M., Lachin J. M., Skyler J. S., Rituximab, B-lymphocyte depletion, and preservation of beta-cell function The New England Journal of Medicine 2009 361 22 2143 2152
115. Bresson D., Togher L., Rodrigo E., Chen Y., Bluestone J. A., Herold K. C., Von Herrath M., Anti-CD3 and nasal proinsulin combination therapy enhances remission from recentonset autoimmune diabetes by inducing Tregs Journal of Clinical Investigation 2006 116 5 1371 1381
116. Bresson D., von Herrath M., Moving towards efficient therapies in type 1 diabetes: to combine or not to combine? Autoimmunity Reviews 2007 6 5 315 322 (Pubitemid 46507996)
117. Matthews J. B., Staeva T. P., Bernstein P. L., Peakman M., Von Herrath M., Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group Clinical and Experimental Immunology 2010 160 2 176 184
118. Shapiro A. M. J., Lakey J. R. T., Ryan E. A., Korbutt G. S., Toth E., Warnock G. L., Kneteman N. M., Rajotte R. V., Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen The New England Journal of Medicine 2000 343 4 230 238 (Pubitemid 30490390)
119. Shapiro A. M. J., Ricordi C., Hering B. J., Auchincloss H., Lindblad R., Robertson R. P., Secchi A., Brendel M. D., Berney T., Brennan D. C., Cagliero E., Alejandro R., Ryan E. A., DiMercurio B., Morel P., Polonsky K. S., Reems JO. A., Bretzel R. G., Bertuzzi F., Froud T., Kandaswamy R., Sutherland D. E. R., Eisenbarth G., Segal M., Preiksaitis J., Korbutt G. S., Barton F. B., Viviano L., Seyfert-Margolis V., Bluestone J., Lakey J. R. T., International trial of the Edmonton protocol for islet transplantation The New England Journal of Medicine 2006 355 13 1318 1330 (Pubitemid 44465460)
120. Collombat P., Xu X., Ravassard P., Sosa-Pineda B., Dussaud S., Billestrup N., Madsen O. D., Serup P., Heimberg H., Mansouri A., The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into and subsequently cells Cell 2009 138 3 449 462
121. Rother K. I., Spain L. M., Wesley R. A., Digon III B. J., Baron A., Chen K., Nelson P., Dosch H.-M., Palmer J. P., Brooks-Worrell B., Ring M., Harlan D.
122. Larch M., Update on the current status of peptide immunotherapy Journal of Allergy and Clinical Immunology 2007 119 4 906 909
123. Achenbach P., Barker J., Bonifacio E., Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization Current Diabetes Reports 2008 8 2 87 93